Clinical trial No longer in our active list Interventional Ages 65 and up

Improving activity levels after aortic valve replacement

Official title: Optimization Post-TAVR to IMprove Activity Levels (OPTIMAL Study)

Run by Johns Hopkins University · NCT06106451 · Data updated 2026-05-14

This study is no longer in our active list. It may have stopped recruiting or finished. The details below are as of 2026-05-14 and are kept for reference. Check ClinicalTrials.gov for its current status, or see similar studies below.

This study is testing whether a special program that combines motivation and home exercise can help people recover and be more active after getting a new heart valve through a minimally-invasive procedure.

Quick facts

Study typeInterventional
Ages65 Years and up
SexAll
Enrollment55 (estimated)
SponsorJohns Hopkins University
Academic / other
Locations1 site (Baltimore, Maryland)
Trial IDNCT06106451 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are patients aged 65 and older who are undergoing a TAVR procedure and are ambulatory without assistance.

Probably not a fit

Patients with significant cognitive impairments, major cardiac comorbidities, or those who engage in vigorous exercise regularly may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study evaluates programs designed to enhance functional outcomes for patients following minimally-invasive transcatheter aortic valve replacement (TAVR). It compares the effectiveness of a motivational interviewing program and a home-based physical activity program combined with motivational interviewing against standard care with enhanced education. The goal is to determine which approach best supports recovery and activity levels in patients post-TAVR.

Why it matters

Potential benefit: If successful, this study could lead to improved recovery and increased activity levels for patients after aortic valve replacement.

How similar studies have gone: Other studies have shown promising results with motivational interviewing and physical activity interventions in similar patient populations, suggesting potential for success in this approach.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Undergoing TAVR procedure
* ≥65 years old
* Ambulatory at baseline without assistance
* Approval of the interventional cardiologist that the patient is an appropriate candidate
* Can access telephone or teleconference

Exclusion Criteria:

* Impaired cognition that would limit participation in study activities
* Medical comorbidities that substantially limit exercise
* Major cardiac comorbidities, including ejection fraction\<35%, history of cardiac arrest, complex dysrhythmias at rest, clinically-significant incomplete revascularization, implanted cardiac defibrillator.
* Physical characteristics that substantially limit exercise
* High fall risk (Johns Hopkins Fall Risk Assessment Tool indicating high risk)
* Non-English Speaking
* Vigorous exercise at least 2 times/week for \>30 minutes
* Any other physician judgement

Where it's running

  • The Johns Hopkins University
    Baltimore, Maryland, United States
    Recruiting

Study contacts

  • Principal investigator: Giancarlo Suffredini, MD — Johns Hopkins University
  • Study coordinator: Charles Brown, MD
  • Email: cbrownv@jhmi.edu
  • Phone: 410-955-9918

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.